Search clinical trials for: Adverse drug event

Total 261895 results

Arianna Anticoagulazione Foundation

Completed

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS) (MAS)

Atrial Fibrillation | Anticoagulant-induced Bleeding

Italy
National Institute of Mental Health and Neuro Sciences...
DyAnsys, Inc.; Vision Group on Science and Technology

Completed

Cardiac Autonomic Dysfunction and Perioperative Outcomes (CADPONS)

Neurosurgical Patients

India
AbbVie
Genentech, Inc.

Active, not recruiting

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

Acute Myeloid Leukemia (AML)

China
Instituto Mexicano del Seguro Social
Germán Ramón Bautista López; Luis Jonathan González; Rodolfo Guardado Mendoza; Gabriel...

Completed

Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI) (DAPA-AMI)

Heart Failure | Angina, Unstable | Acute Myocardial Infarction | Cardiovascular Morbidity

Mexico
Damanhour University

Completed

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Ciprofloxacin Adverse Reaction

Egypt
Assistance Publique - Hôpitaux de Paris
Fédération Française de Cardiologie; BioSerenity

Completed

Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors (AMICI)

Cancer | Cardiovascular Abnormalities | Immune Defect

France
Medstar Health Research Institute

Completed

Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy

Incidence of Major Adverse Cardiac Events

United States
Shiraz University of Medical Sciences

Completed

Ticagrelor vs. Clopidogrel in Post PCI Patients

Stable Chronic Angina

Iran, Islamic Republic of
Scripps Health

Completed

Adverse Events Related to Low Dose Atropine (AELDA)

Myopia, Progressive

United States
Groupe Hospitalier Pitie-Salpetriere
CMC Ambroise Paré

Completed

Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

Iatrogenic Disease | Acute Kidney Injury | Coronavirus | ARDS, Human

France
H. Lee Moffitt Cancer Center and Research Institute
ModernaTX, Inc.

Completed

COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients

Covid19 | SARS-CoV2 Infection

United States
Groupe Hospitalier Pitie-Salpetriere

Completed

Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events (CARTABLE)

Cancer | Adverse Drug Reactions

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) (APSTOX)

Antiphospholipid Syndrome | Adverse Drug Event | Drug Toxicity | Immune Disease

France
Groupe Hospitalier Pitie-Salpetriere

Completed

Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA) (EROCA)

Cancer | Cardiac Disease

France
Allergan

Active, not recruiting

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

Mid Face Volume Deficit

Canada, Spain, United Kingdom
Groupe Hospitalier Pitie-Salpetriere

Completed

Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX) (AmmoTOX)

Metabolic Disease | Adverse Drug Event | Hyperammonemia | Drug Toxicity

France
The Ottawa Hospital

Completed

Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform

Mobile Apps | Immunization | Adverse Event Following Immunisation

Canada
Insight Therapeutics, LLC
Brown University; Sanofi Pasteur, a Sanofi Company; Case Western Reserve University

Active, not recruiting

Recombinant Influenza Vaccination in U.S. Nursing Homes

Influenza | Influenza, Human | Influenza -Like Illness

United States
AbbVie

Terminated

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

Multiple Myeloma

United States, Australia, France, Germany, Israel, Japan, Spain
Hospital de Niños R. Gutierrez de Buenos Aires

Active, not recruiting

Nifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment

Chagas Disease

Argentina
Ohio State University Comprehensive Cancer Center
Cancer and Leukemia Group B

Completed

Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer

United States
GlaxoSmithKline

Completed

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Neoplasms, Rectal

Korea, Republic of
Cipherome, Inc.
Stanford University

Completed

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia, Pediatric | Adverse Drug Event

United States
University of Texas Southwestern Medical Center

Terminated

7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events

Muscle Cramp | Statin Adverse Reaction | Weakness, Muscle | Ache

United States
AbbVie

Enrolling by invitation

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 (OptIMMize-2)

Psoriasis

United States, Canada, Germany, Japan, Poland, Spain, United Kingdom
Getz Pharma

Completed

Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus (RISE)

Type 2 Diabetes Treated With Insulin | Adverse Drug Event | Effect of Drug

Pakistan
Novartis Pharmaceuticals

Completed

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

Melanoma

United States
Tabula Rasa HealthCare

Withdrawn

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Elderly | Adverse Drug Event | Pharmacogenomics | Drug Drug Interaction

United States
Xijing Hospital of Digestive Diseases

Completed

The Efficacy of N-acetylcysteine on Alleviating Symptom Caused by Lugol Chromoendoscopy

Esophageal Squamous Cell Carcinoma

China
GlaxoSmithKline
PATH; Iqvia Pty Ltd; AMP (Agence de Médecine Préventive) (in French); RAFT (Réseau... and other collaborators

Completed

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine

Malaria | Malaria Vaccines

Ghana, Burkina Faso, Kenya
Duke University
Boston Medical Center; Centers for Disease Control and Prevention; Children's...

Completed

Safety of RIV4 Versus IIV4 in Pregnant Women

Safety | Birth Outcomes | Adverse Event Following Immunisation

United States
Nanjing Medical University

Completed

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine Immune-related Adverse Events (irAEs)

Immune Checkpoint Inhibitor | Endocrine Toxicity

China
Jazz Pharmaceuticals

Completed

A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

Epilepsy

United Kingdom
Novo Nordisk A/S

Completed

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

Obesity

Mexico
Centre hospitalier de l'Université de Montréal...
Sunnybrook Health Sciences Centre; University of Alberta; Unity Health Toronto; University of Kentucky and other collaborators

Completed

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury (ECHO-AKI)

Acute Kidney Injury | Ultrasonography | Fluid Overload

Canada, United States
Allergan

Completed

A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age (TAURUS)

Presbyopia

Australia
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (ALTERNATIVE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders

United States
University of Southern Denmark
Odense University Hospital

Completed

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Breast Cancer | Gastric Cancer | Rectal Cancer | Bile Duct Cancer | Colon Cancer | Pancreas Cancer | Oesophageal Cancer | Adverse Drug Event

Denmark
Hospital San Carlos, Madrid

Completed

Safety and Efficacy of Medications COVID-19

Severe Covid-19

Spain
National Taiwan University Hospital
Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Completed

Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination

Healthy Adult Volunteers

Taiwan
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation; Meilleur Accès aux Soins de Santé (M.A....

Completed

Extended Dose Intervals With Oral Cholera Vaccine in Cameroon

Cholera Vaccination Reaction | Adverse Reaction to Cholera Vaccine

Cameroon
VA Office of Research and Development
The George Institute

Completed

Prevention of Serious Adverse Events Following Angiography (PRESERVE)

Coronary Artery Disease | Acute Renal Failure | Kidney Disease

United States, Australia, New Zealand, Malaysia
Washington University School of Medicine
Center for Research on Filariasis and Other Tropical Diseases, Cameroon

Completed

Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

Loiasis

Cameroon
Pfizer

Completed

To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States
AbbVie
Roche-Genentech

Completed

Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function

Renal Impairment | Renal Disease

United States
General Hospital of Ningxia Medical University

Completed

Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension

Adverse Event

China
Tabula Rasa HealthCare
Cambia Health Solutions

Enrolling by invitation

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

COVID | Drug Effect | Adverse Drug Event | Drug Interaction

United States
Tabula Rasa HealthCare

Enrolling by invitation

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

COVID | Drug Effect | Adverse Drug Event | Drug Interaction

United States
Tabula Rasa HealthCare

Withdrawn

Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications

COVID | Drug Effect | Risk Reduction | Drug Interaction

United States
Universitaire Ziekenhuizen KU Leuven

Completed

The Impact of a Pharmacist Intervention on Post-discharge Hypnotic Drug Discontinuation in Geriatric Inpatients

Hypnotic Withdrawal

Search clinical trials for: Adverse drug event

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations